UniQure CEO Soland makes a quick exit as execs hammer out a new strategy
Nine months after landing a new job as CEO of the Dutch gene therapy biotech uniQure, Dan Soland abruptly quit on Thursday, saying the unexpected …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
